Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

AMD CEO Lisa Su Believes Its Deal With Meta Platforms Will Be a Triple-Digit Billion Dollar Deal: https://g.foolcdn.com/editorial/images/860191/new-cc-2026-03-05t093503285.png
AMD CEO Lisa Su Believes Its Deal With Meta Platforms Will Be a Triple-Digit Billion Dollar Deal

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD) and other AI stocks. To learn more, check out the short video, consider subscribing, and click the special

EQS-Adhoc: Gerresheimer AG: Publication of the 2025 annual and consolidated financial statements only after March 31, 2026, exclusion from the SDAX, postponement of the Annual General Meeting
EQS-Adhoc: Gerresheimer AG: Publication of the 2025 annual and consolidated financial statements only after March 31, 2026, exclusion from the SDAX, postponement of the Annual General Meeting
EQS-Adhoc: Gerresheimer AG: Publication of the 2025 annual and consolidated financial statements only after March 31, 2026, exclusion from the SDAX, postponement of the Annual General Meeting
2 Growth Stocks to Hold for the Next Decade: https://g.foolcdn.com/editorial/images/859409/surgeons-in-an-operating-room.jpg
2 Growth Stocks to Hold for the Next Decade

Over the past year, Intuitive Surgical (NASDAQ: ISRG) and DexCom (NASDAQ: DXCM) have faced headwinds, and have lagged the stock market as a result. Shares of the former are down 13% over the

3 Reasons Not to Sleep on ResMed Stock: https://g.foolcdn.com/editorial/images/854968/getty-peace-of-mind-sleep-at-night-financial-security.jpg
3 Reasons Not to Sleep on ResMed Stock

I confess: I've been sleeping on ResMed (NYSE: RMD) stock, not paying much attention to it at all. But maybe I shouldn't ignore it -- and you may not want to, either.

Here are three reasons why it's

2 Healthcare Stocks That Are Too Cheap to Ignore: https://g.foolcdn.com/editorial/images/859405/doctor-and-patient-in-a-hospital-room.jpg
2 Healthcare Stocks That Are Too Cheap to Ignore

Some indicators suggest that equity markets are currently overvalued. For instance, the S&P 500 Shiller CAPE ratio is near multi-year highs. In this environment, it pays to look for bargains, stocks

VALBIOTIS SA: Valbiotis raises awareness of cardiometabolic risks with the Cœur en Jeu prevention campaign
VALBIOTIS SA: Valbiotis raises awareness of cardiometabolic risks with the Cœur en Jeu prevention campaign
VALBIOTIS SA: Valbiotis raises awareness of cardiometabolic risks with the Cœur en Jeu prevention campaign
Investment Firm Sheds 384,000 Shares of VERX Stock, According to Latest SEC Filing: https://cdn.content.foolcdn.com/images/1umn9qeh/production/6f699693a3501babe6eb40aac5d3061bf74bda96-1401x1251.png?rect=76,0,1251,1251&w=384&h=384&q=75&fit=crop&auto=format
Investment Firm Sheds 384,000 Shares of VERX Stock, According to Latest SEC Filing

On February 17, 2026, Tensile Capital Management LP reported selling 384,415 shares of Vertex (NASDAQ:VERX) in the fourth quarter, an estimated $8.32 million trade based on quarterly average

AMD's Multi-Billion-Dollar AI Deal: Why GPU Revenue Could Drive Steady Gains: https://g.foolcdn.com/editorial/images/858902/amd_in_front_of_hq_building.png
AMD's Multi-Billion-Dollar AI Deal: Why GPU Revenue Could Drive Steady Gains

How can Advanced Micro Devices (NASDAQ: AMD) turn AI design wins and a multi‑billion dollar GPU deal into durable revenue, despite fierce competition from competitors? Watch the video below for key

EQS-News: Evotec Announces ‘Horizon’ – Next Inflection in Its Strategic Transformation to Accelerate Growth and Promote Agility
EQS-News: Evotec Announces ‘Horizon’ – Next Inflection in Its Strategic Transformation to Accelerate Growth and Promote Agility
EQS-News: Evotec Announces ‘Horizon’ – Next Inflection in Its Strategic Transformation to Accelerate Growth and Promote Agility
Stock Market Today, March 9: Nvidia Rises Ahead of GTC as Investors Watch for AI Chip Announcements: https://cdn.content.foolcdn.com/images/1umn9qeh/production/23fc1b822f8eafa9d627ca7fbac8d5b39aebf467-1401x1251.png?rect=76,0,1251,1251&w=384&h=384&q=75&fit=crop&auto=format
Stock Market Today, March 9: Nvidia Rises Ahead of GTC as Investors Watch for AI Chip Announcements

Nvidia (NASDAQ:NVDA), designs GPUs and AI hardware for gaming and data centers. The stock closed Monday at $182.65, up 2.68%. Investors focused on anticipated artificial intelligence hardware

Axsome Therapeutics CEO Completes Planned $6 Million Options Sale Ahead of Pivotal FDA Decision: https://cdn.content.foolcdn.com/images/1umn9qeh/production/1a599f395be31e2f508c3aa7decb988f9ce983b7-1401x1251.png?rect=76,0,1251,1251&w=384&h=384&q=75&fit=crop&auto=format
Axsome Therapeutics CEO Completes Planned $6 Million Options Sale Ahead of Pivotal FDA Decision

Herriot Tabuteau, CEO of Axsome Therapeutics (NASDAQ:AXSM), exercised and immediately sold 32,410 common shares in an open-market transaction on February 2, 2026, as disclosed in the SEC Form 4

Cytokinetics Insider Exercises Options Worth Over $920,000 as Heart Drug Hits the Market: https://cdn.content.foolcdn.com/images/1umn9qeh/production/782b0b9f4f412d891de6f8f7670abc6b1a621e10-1401x1251.png?rect=76,0,1251,1251&w=384&h=384&q=75&fit=crop&auto=format
Cytokinetics Insider Exercises Options Worth Over $920,000 as Heart Drug Hits the Market

On Feb. 5, 2026, Andrew Callos, Executive Vice President and Chief Commercial Officer of Cytokinetics (NASDAQ:CYTK), exercised 15,000 options for common stock and immediately sold the resulting

Pfizer's Payout Ratio Is Still Over 100%. Is a Dividend Cut Inevitable?: https://g.foolcdn.com/editorial/images/859726/a-person-flipping-through-dollar-bills.jpg
Pfizer's Payout Ratio Is Still Over 100%. Is a Dividend Cut Inevitable?

A key ratio for dividend investors when looking at dividend stocks is the payout ratio. Since it tells you how large the dividend is with respect to earnings, it can be a good gauge of whether or

2 Top AI Healthcare Stocks to Buy and Hold: https://g.foolcdn.com/editorial/images/859008/pharmacist-talking-to-patient.jpg
2 Top AI Healthcare Stocks to Buy and Hold

Many of the top companies successfully cashing in on artificial intelligence (AI) are in the technology sector. However, AI is having an impact across every industry, and plenty of companies outside

Forget AI Stocks: This Potentially Disruptive Biotech Could Soar By 181%, According to Wall Street: https://g.foolcdn.com/editorial/images/859826/person-raising-two-fists-in-the-air.jpg
Forget AI Stocks: This Potentially Disruptive Biotech Could Soar By 181%, According to Wall Street

Some artificial intelligence (AI)-focused companies have delivered exceptional returns over the past few years, but some investors and analysts now believe we are in an AI bubble ready to burst.

Rice Hall James Buys QuidelOrtho Stock: https://cdn.content.foolcdn.com/images/1umn9qeh/production/6692d59793d1ea90a718aa18b7a3ace7f41e99ee-1401x1251.png?rect=76,0,1251,1251&w=384&h=384&q=75&fit=crop&auto=format
Rice Hall James Buys QuidelOrtho Stock

On Feb. 13, 2026, Rice Hall James & Associates, LLC disclosed a buy of QuidelOrtho (NASDAQ:QDEL) in the fourth quarter.

An SEC filing dated Feb. 13, 2026, shows Rice Hall James & Associates, LLC

Buying This 1 Biotech Stock Now Could Help Make You a Multimillionaire Retiree: https://g.foolcdn.com/editorial/images/855031/person-raising-two-fists-in-the-air.jpg
Buying This 1 Biotech Stock Now Could Help Make You a Multimillionaire Retiree

Everyone should save money for retirement, since programs such as Social Security aren't meant to replace workers' entire income and face potential cuts. Building a big nest egg for your post-work

This Cathie Wood Stock Is Up 47% This Year: Is It Too Late to Buy?: https://g.foolcdn.com/editorial/images/858985/scientist-altering-dna-genome-project.jpg
This Cathie Wood Stock Is Up 47% This Year: Is It Too Late to Buy?

Cathie Wood, the CEO of the investment management firm Ark Invest, is known for focusing on companies with significant innovative potential. One of her firm's picks, Intellia Therapeutics (NASDAQ:

Better Weight Loss Stock: Novo Nordisk Vs. Amgen: https://g.foolcdn.com/editorial/images/858881/patient-talking-with-a-physician.jpg
Better Weight Loss Stock: Novo Nordisk Vs. Amgen

The weight-loss market has become one of the most active therapeutic areas in the pharmaceutical industry over the past few years. And based on analyst projections, it will continue growing at a

2 No-Brainer Dividend Stocks to Buy in 2026: https://g.foolcdn.com/editorial/images/858996/physician-talking-to-patient.jpg
2 No-Brainer Dividend Stocks to Buy in 2026

Dividend stocks are not all the same. Some will readily decrease or suspend their payouts at the first sign of trouble, while others will continue increasing them even during market downturns or

2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $1,000: https://g.foolcdn.com/editorial/images/857160/25_12_29-a-surgical-robot-_robotic-surgery-surgical-equipment-1067x800-9f8a157.jpg
2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $1,000

Most investors don't associate the healthcare sector with dividends, but there are some pretty impressive dividend stocks to be had. Two that stand out today are Becton, Dickinson (NYSE: BDX) and

2 Underrated Weight Loss Stocks to Buy Now: https://g.foolcdn.com/editorial/images/859799/patient-self-administering-a-shot.jpg
2 Underrated Weight Loss Stocks to Buy Now

Investors who want to capitalize on the growing weight loss market might be tempted to turn to the current leaders in the field, Eli Lilly and Novo Nordisk. Both companies are worth serious

Lockheed vs. Anduril: Who Will Build the Army's Next Great Command and Control System?: https://g.foolcdn.com/editorial/images/859124/military-soldiers-at-computer-screens-monitor-satellite-imaging.jpg
Lockheed vs. Anduril: Who Will Build the Army's Next Great Command and Control System?

When it comes to acronyms, the U.S. Army's Next Generation Command and Control program got the short end of the stick.

Named "NGC2," the Army's attempt to build a new command and control system

Here's Why I Wouldn't Touch Amarin With a 10‑Foot Pole Given Its Patent and Competition Risks: https://g.foolcdn.com/editorial/images/854886/23_10_30-a-pharmacist-helping-a-customer-with-a-medicine-prescription-mf-dloadjpgcrdownload.jpg
Here's Why I Wouldn't Touch Amarin With a 10‑Foot Pole Given Its Patent and Competition Risks

Amarin (NASDAQ: AMRN) is a drug company that is in a particularly precarious position. This fact is highlighted by the company's recent move to restructure its operations in an effort to cut costs

The Best Stocks to Invest $1,000 in Right Now: https://g.foolcdn.com/editorial/images/858441/gettyimages-2189138240.jpg
The Best Stocks to Invest $1,000 in Right Now

If you've got $1,000 to invest, I think two stocks trading right around $200 a share look quite attractive. With that amount of money, you'd be able to buy five shares of one stock or split it up